Find out how scientists are maximizing retinal organoid effectiveness to sustain critical retinal ganglion cells.
Apellis Pharmaceuticals (NASDAQ:APLS) said early Thursday that a total of ten cases of retinal vasculitis have been confirmed with two more suspected among recipients of its eye medication Syfovre.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results